Global Fund Results Report Reveals COVID-19 Devastating Impact on HIV, TB and Malaria Programs

GENEVA – The COVID-19 pandemic had a devastating impact on the […]

World Hepatitis Day 2021: Unitaid paving the way for hepatitis C elimination

Unitaid has invested more than US$ 45 million into hepatitis […]

Innovative agreement launches affordable, optimal second-line HIV treatment in low- and middle-income countries

COVAX and World Bank to Accelerate Vaccine Access for Developing Countries

FIND and Unitaid invest to support technology transfer and boost local production of COVID-19 rapid tests in low- and middle-income countries

Global Fund Applauds Switzerland’s Leadership in The Global Fight Against COVID-19

14 July 2021

GENEVA – The Global Fund to Fight AIDS, Tuberculosis […]

New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide

Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX

Unitaid statement on WHO recommendations for tocilizumab and sarilumab

Joint COVAX Statement on the equal recognition of vaccines